Hematology-Oncology Clinical Questions

Julie Rowe, Anneliese Gonzalez, Syed Jafri, Putao Cen, Zeyad Kanaan (Autoren)

Buch | Softcover

608 Seiten

2019
McGraw-Hill Education (Verlag)
978-1-260-02662-7 (ISBN)

Artikel merken

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.

A unique point-of-care guide to clinical hematology-oncology that answers the most frequently asked questions

Hematology-Oncology Clinical Questions is the single-best resource for quickly converting the most current data and research into practical, diagnostic real-time solutions. This unique book answers more than 60 of the clinical hematology-oncology questions most commonly asked of the authors during consultation. The content flow simulates the consultation process: Question…Data…Synthesis…Solution.

The initial chapters prepare you with essential background fundamentals of hematology-oncology. Subsequent chapters are divided into tumor type, beginning with solid tumor types, and then hematological malignancies. Each chapter includes:

• Key Concepts
• The Clinical Scenario
• The Action Items
• Pearls

Hematology-Oncology Clinical Questions will prove to be a powerful tool to help learners from all points of the clinical spectrum understand the basic concepts of caring for a cancer patient.

Julie H. Rowe, MD; Anneliese O. Gonzalez, MD; SyedH. Jafri, MBBS.; Putao Chen, MD; Zeyad Kanaan, MD; and Robert J. Amato, DO, Adan Rios, MD, Hazem El-Osta, MD are affiliated with The University of Texas Health Scienceat Houston, McGovern Medical School.

Table of Contents

1. CHEMOTHERAPY AGENTS –WILL INCLUDE A SUMMARY OF EACH TYPE BEFORE CLINICAL QUESTIONS

a. Cytotoxic

b. Targeted Agents

c. Hormonal Agents

d. Immunotherapy

2. RADIATION THERAPY

3. MOST COMMON HEME QUESTIONS

a. Anemia

b. Thrombocytopenia

c. Thrombosis

d. Transfusion reactions

4. SCREENING

a. Breast cancer

b. Cervical

c. Colon Cancer

d. Prostate

e. Lung Cancer

5. BREAST CANCER

a. Non-invasive

b. Invasive

c. Inflammatory breast cancer

d. Phyllodes

e. Paget’s

6. HEAD AND NECK

7. THYROID CARCINOMAS

8. GI CANCER

a. Esophagus

b. Gastric/GEJ

c. Colon

d. Rectal

e. Anus

f. Pancreas

g. Cholangiocarcinoma

h. Hepatocellular Carcinoma

i. Neuroendocrine tumors

9. GU CANCER

a. Bladder

b. Kidney

c. Prostate

d. Testicular

10. GYNECOLOGICAL MALIGNANCIES

a. Cervical

b. Endometrial

c. Ovarian

d. Uterine

11. MELANOMAS

12. THORACIC

a. Small cell lung cancer

b. Non-small cell lung cancer

13. SARCOMAS

14. OCCULT PRIMARY

15. BASICS OF PATHOLOGY AND HEMATOLOGY

a. Bone Marrow, Flow Cytometry, Cytogenetics, Molecular testing.

b. Solid tumor pathology basics

16. BASICS OF BONE MARROW TRANSPLANTATION

a. Types (Allo, Auto)

b. Indications

17. LYMPHOMAS

a. Hodgkin’s Lymphoma

i. Classical HL

ii. Nodular lymphocyte-predominant HL

b. Non-Hodgkin’s Lymphoma

i. B-cell NHL

a) Diffuse large B-cell Lymphoma (DLBCL)

b) Follicular Lymphoma

c) Mantle Cell Lymphoma (MCL)

d) Small Lymphocytic Lymphoma (SLL)

e) Primary CNS Lymphoma

f) Primary Mediastinal Lymphoma (PML)

g) Burkitt Lymphoma (BL)

h) Primary Effusion Lymphoma

i) Double-hit Lymphoma

j) Primary Effusion Lymphoma (PEL)

ii. T-Cell NHL

a) Peripheral T-cell Lymphoma (PTCL)

b) Primary Cutaneous T-cell Lymphoma

c) Anaplastic Large Cell Lymphoma (ALCL)

d) Post-Transplant Lymphoproliferative

18. LEUKEMIAS

a) Acute Leukemias

i. Acute Myeloid Leukemia (AML)

ii. APL

i. Acute Lymphoblastic Leukemia (ALL)

b) Chronic Leukemias:

i. Chronic Myeloid Leukemia (CML)

ii. Chronic Lymphocytic Leukemia (CLL)

iii. Hairy Cell Leukemia

19. PLASMA CELL DISORDERS:

a. Monoclonal Gammopathy of Undetermined Significance (MGUS)

b. Multiple Myeloma (MM)

c. Lymphoplasmacyctic Lymphoma (including Waldenstrom’s Macroglobulinemia)

d. Solitary Plasmacytoma

e. AL Amyloidosis

f. POEMS Syndrome

20. MYELOPROLIFERATIVE NEOPLASMS

a. Polycythemia Vera (PV)

b. Essential Thrombocythemia (ET)

c. Primary Myelofibrosis (PMF)

d. Systemic Mastocytosis (SM)

21. MYELODYSPLASTIC SYNDROMES

22. GUIDELINES FOR SUPPORTIVE CARE

a. Management of Side Effects of Chemotherapy

i. Myelosuppression

ii. Nausea

iii. Vomiting

iv. Diarrhea

v. Mucositis

vi. Anorexia, weight loss

b. Management of Cancer-related pain

c. Management of Cachexia

23. ONCOLOGIC EMERGENCIES

a. Neutropenic Fever

b. Spinal Cord Compression

c. Tumor Lysis Syndrome

d. Superior vena cava syndrome

e. Hypercalcemia of malignancy

f. Hyperleukocytosis and leukostasis

24. GENETIC AND FAMILIAL ASSESSMENT
FOR FAMILIAL CANCER SYNDROMES

25. END OF LIFE

Erscheinungsdatum	20.12.2018
Zusatzinfo	60 Illustrations
Verlagsort	OH
Sprache	englisch
Maße	114 x 178 mm
Gewicht	522 g
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Hämatologie
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
ISBN-10	1-260-02662-0 / 1260026620
ISBN-13	978-1-260-02662-7 / 9781260026627
Zustand	Neuware